Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer
暂无分享,去创建一个
K. Nikolaou | U. Kramer | M. Notohamiprodjo | A. Stenzl | J. Bedke | J. Hennenlotter | S. Kaufmann | S. Gatidis | S. Kruck | Sascha Kaufmann | Jens Bedke | Stephan Kruck | S. Gatidis | A. Stenzl | Ulrich Kramer | Konstantin Nikolaou | Jörg Hennenlotter